Diagnostic and therapeutic considerations in patients with bilateral diffuse uveal melanocytic proliferation

ConclusionsBDUMP can be considered a potential biomarker in the management of malignancies, especially when the primary underlying tumor has not been detected. Further research is needed to better understand the pathogenesis of BDUMP and its association with malignancy.
Source: International Ophthalmology - Category: Opthalmology Source Type: research